Tuberculosis remains a significant problem in Australia with five to six new cases per 100,000 of the population per year. The majority of cases occur in individuals born outside Australia. Approximately 70% is pulmonary disease and 30% nonpulmonary. Diagnosis can be made by history, clinical examination, Mantoux testing, chest X-ray plus a thoracic CT scan and sputum analysis. Occasionally bronchoscopy and/or fine needle aspiration biopsy may be indicated. Six months of appropriate supervised chemotherapy achieves a 98% cure. Healthcare workers are at special risk of infection and should have Mantoux testing; if this is negative then either BCG or regular Mantoux surveillance is recommended. Whilst multi-drug resistant tuberculosis is relatively uncommon in Australia, it is a significant problem in the United States and parts of South East Asia and such patients often come to surgical resection of their tuberculous lesions; during such resection healthcare workers are exposed to a potentially lethal infection.
Tuberculosis, particularly pulmonary disease, is still extremely common throughout the world. It is estimated that each year there are five million new smear-positive cases with a probable further five million smear-negative cases, and tuberculosis causes the death of between three and four million people per year worldwide. The highest prevalence of tuberculosis infection is in sub-Saharan Africa and South East Asia with nearly 50% of all reported cases of tuberculosis occurring in South East Asia. In Australia notification rates of all tuberculosis cases have remained stable at between 5.5 and 5.9 new cases of tuberculosis per 100,000 of the population per year during the period 1986 to 1992. (Range 3.4 in Tasmania to 18.97 in the Northern Territory.) This compares with an incidence of 50 per 100,000 of the population per year in 1948. Rates in some parts of South East Asia are 1,500 per 100,000 of the population per year. Australia has one of the lowest rates of tuberculosis in the world and its rates compare favourably with, for example, Canada (7.7 per 100,000 per year) and New Zealand (9.2 per 100,000 per year). Death rates from tuberculosis in Australia have remained stable over the last ten years at about 0.4 per 100,000 of the population per year. There were 991 tuberculosis notifications in 1993 in Australia, with a male to female ratio of 1:0.87. There are two peaks in incidence in Australia; the first in the 20 to 44 year age group and the second in the over 55 year age group: the highest rates are in those over 80 where the incidence is 17.5 per 100,000 per year. The rate per 100,000 for people born in Australia is 1.8 and for those born overseas 14.6; of the population born overseas the highest rates were in those born in the Philippines (95 per 100,000) 1 . Overall, 70 to 85% of annual notifications of active tuberculosis in Australia occur in people born outside Australia; 50% of these present within five years of arrival and 40% do not present until the patient has lived in Australia for more than ten years.
Microbiology
Mycobacterium tuberculosis is an aerobic organism which thrives best at a pH of 7.4 and a PO 2 of 100 to 140 mmHg. The organism divides only every 16 to 24 hours and to be visible microscopically there must be 10,000 organisms per ml of sputum. The slow division of the organism means that antibiotic therapy for the disease can be given once a day or less frequently. The only significant mode of transmission of tuberculosis is the aerogenic route such that airborne particles are liberated into the atmosphere with coughing, sneezing, talking etc. These respiratory droplets are large particles which tend to settle in room dust and are too large to penetrate lower airways. Upon drying, smaller droplet nuclei of 1.0 to 5.0 microns diameter develop and can spread into the atmos-phere and particles less than 2 microns in size can penetrate the lower airways 2 . These droplet nuclei spread throughout the atmosphere and may be inhaled by others and infection occurs. More rarely, disease may spread from an infected patient during surgery or the processing of pathological specimens. Tuberculosis is a highly infectious disease and its spread is facilitated by small, poorly ventilated indoor areas and where there is overcrowding.
Clinical Features
There are certain high-risk groups for the development of tuberculosis in Australia and these are listed in Table 1 . The clinical features vary widely and are nonspecific. They include general symptoms such as tiredness, malaise, weight loss and night sweats and more specific symptoms such as cough, sputum, haemoptysis and chest pain. The patient may present with pneumonia. It is important to remember that tuberculosis may be well advanced before any symptoms are sufficient for the patient to seek medical attention. Approximately 70% of new cases of tuberculosis in Australia are pulmonary and 30% extrapulmonary. Lymph node tuberculosis is the commonest nonpulmonary disease and accounts for one third of it.
Signs found on examination will vary depending upon the site of the disease. Signs in the chest are nonspecific; there may be none or there may be localized crepitations particularly in the upper lobes posteriorly. A pleural effusion may be present. Cervical lymphadenopathy is the commonest sign in lymph node tuberculosis.
Diagnosis
The most important aspect of diagnosis is to have a high index of suspicion of the disease particularly for patients born outside Australia. In such individuals with undiagnosed respiratory disease, tuberculosis should be considered possible until proved otherwise and appropriate care taken.
Following a history and physical examination the diagnosis can usually be established by a number of investigations (see Table 2 Pulmonary tuberculosis nearly always causes detectable abnormalities on the chest radiograph. In adults the disease tends to be posterior when the lateral radiograph is viewed, with involvement of the apical and posterior segments of the upper lobe and the apical segment of the lower lobe.
Multiple sputum smears and cultures for acid-fast bacilli are important in the diagnosis. Rapid microbiological techniques are now available and if the patient is producing satisfactory sputum then the microbiological laboratory will be able to identify Mycobacterium tuberculosis, if present, on the same day. If there is no sputum being produced but there are chest X-ray lesions suggestive of pulmonary tuberculosis then a bronchoscopy with washings and brushings of the particular segment and/or a fine needle aspiration biopsy of the lesion under computerized tomography control may be indicated. A thoracic CT scan may be useful to further elucidate the nature of the pulmonary X-ray changes, particularly the presence or absence of cavitation or calcification.
Treatment
Some important principles of treatment are: 1. It is generally best, if possible, not to begin treatment until positive bacteriology has been confirmed. 2. Admission to hospital is usually only required for a very short time (a few days) in order to establish the diagnosis and commence therapy. 3. Drug therapy must be continued for a minimum of six months and needs to be supervised. It can be given three times a week for the duration of treatment. 4. The main drugs used in the treatment of tuberculosis are isoniazid, rifampicin, pyrazinamide and ethambutol. 5. Using these drugs with supervision one can expect a 98% cure for tuberculosis. Of the very small number of relapses that do occur the vast majority occur within the first year of completing chemotherapy and almost all within two years of cessation of chemotherapy. Therefore it is considered only necessary to follow the patients for two years after the cessation of therapy. Details of therapy are beyond the scope of this article and can be read in other texts 3,4. 
HIV and Tuberculosis
Tuberculosis is one of the commonest opportunistic infections in patients with HIV/AIDS infection. Unlike the other opportunistic infections, however, tuberculosis is also highly infectious to normal individuals, so that as the incidence of HIV infection increases in the community, so does the possibility for a second wave of tuberculosis infections to occur in the non HIV infected population 5 . Tuberculosis, when it complicates HIV disease, may be due to either reactivation or new exogenous infection. In the United Kingdom, 5-6% of AIDS cases have tuberculosis during their clinical course 6 . In Australia, infection of AIDS patients with Mycobacterium tuberculosis is relatively uncommon, infection with atypical mycobacterial disease such as M.avium being considerably more common. Anybody with HIV disease should, however, be considered a potential source of tuberculosis infection. Successful treatment of tuberculosis in patients with HIV disease is good, with the standard six-month regimen being recommended followed by isoniazid for life to prevent relapse 7 .
Multi-Drug Resistant Disease
Of major recent concern world wide is the emergence of multi-drug resistant Mycobacterium tuberculosis. The organism is resistant to both isoniazid and rifampicin and is usually resistant to other drugs as well. This is a particular problem in the United States of America and in parts of South East Asia 8 . Resistance to at least one of the common anti-tuberculosis drugs in Australia occurs in around 14% of isolates, but fortunately fewer than 1% of isolates are resistant to isoniazid and rifampicin in combination. At this stage multi-drug resistant tuberculosis in Australia is rare but the potential for it to increase with visitors, migrants and refugees arriving in Australia carrying the infection is real and worrying as this form of the disease is difficult to treat and has a mortality of up to 40%.
Tuberculosis and Healthcare Workers
Healthcare workers are at special risk of being infected with Mycobacterium tuberculosis and developing disease. All healthcare workers in regular contact with patients, processing patient specimens or involved in mortuary work, need to be aware of the potential for infection with tuberculosis either from patients with known disease or more commonly from patients or specimens not known to be infected with Mycobacterium tuberculosis. All medical personnel, nurses, wardsmen, pathology, radiology, dental, A. B. X. BRESLIN Anaesthesia and Intensive Care, Vol. 24, No. 2, April 1996 All healthcare workers should have an exit Mantoux and chest X-ray on completion of their employment at any particlar healthcare facility. Certain healthcare workers are at higher risk of being exposed to infectious tuberculosis than are others. High risk category workers are listed in Table 4 . Staff involved in the management of diagnosed cases of tuberculosis are at no greater risk of contracting the disease than other staff in the hospital. In fact, there is a greater risk of contracting tuberculosis from undiagnosed cases. Immunocompromised members should not work on wards where there are active cases of tuberculosis. Universal precautions should always be taken. Body substance isolation precautions should apply when handling sputum and other infected body substances. Masks should be worn when entering the room of a patient with active tuberculosis who is not yet on drug therapy for it.
Tuberculosis and Anaesthetists
Anaesthetists, like all heathcare workers involved in direct patient contact, run the risk of contracting tuberculosis. The risk is low, however, based on anecdotal evidence. The risk can be minimized by following the procedures recommended above. Tuberculosis is entirely curable if the diagnosis is made promptly and appropriate therapy commenced and supervised.
A potentially hazardous situation exists in relation to multi-drug-resistant tuberculosis. Although uncommon in Australia so far, it has a mortality of up to 40% and patients with the disease often require surgical resection of the infected areas, particularly pulmonary cavities. In such circumstances theatre staff are exposed to a potentially serious risk of being infected with multi-drug-resistant organisms. Extreme care must be taken in such situations and recommendations have been published concerning such surgery 9 . Ideally elective operative procedures on patients who have tuberculosis should be delayed until the patient is no longer infectious but with multi-drug-resistant disease this may not be possible. A bacterial filter should be placed on the endotracheal tube to help reduce the risk of contamination of the anaesthetic equipment and of discharging tubercle bacilli into the ambient air. During postoperative recovery, the patient should be placed in a room that meets recommended standards for ventilating tuberculosis isolation rooms, including negative pressure inside the room and venting air to outside the building. Healthcare workers in the operating theatre during surgery for multi-drugresistant disease should wear masks of more efficient quality than normal surgical masks. It is suggested that the particular situation be discussed with microbiological and respiratory experts in the institution before the surgery is undertaken. 
